Skip to content
Evigrade
CriticalAntidepressants. Other antidepressants of herbal origin×Selective serotonin reuptake inhibitor (SSRI)

Updated · Methodology

Mechanism

St John's wort extract inhibits the synaptosomal reuptake of serotonin, noradrenaline and dopamine (St John's wort summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 5.1), and paroxetine is a selective serotonin reuptake inhibitor (SSRI). The interaction table of the St John's wort SmPC lists increased serotonergic effects and a higher incidence of adverse reactions with SSRIs, including paroxetine (St John's wort SmPC, AEMPS, section 4.5). The European Medicines Agency (EMA) herbal monograph gives paroxetine as an example of an antidepressant whose serotonergic effects St John's wort may add to (St John's wort herbal monograph, EMA, section 4.5). The paroxetine SmPC states that combination with serotonergic agents, St John's wort preparations among them, may lead to 5-HT-associated effects, which can extend to serotonin syndrome (paroxetine SmPC, AEMPS, section 4.5).

Symptoms

According to the Spanish paroxetine summary of product characteristics (SmPC), serotonin syndrome can be life-threatening. Its features are hyperthermia, rigidity, myoclonus, autonomic instability with possible rapid fluctuations of vital signs, confusion, irritability and extreme agitation that may progress to delirium and coma (paroxetine SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.4). The paroxetine label of the US Food and Drug Administration (FDA) also lists hallucinations, dizziness, sweating, flushing, tremor, hyperreflexia, incoordination, seizures, nausea, vomiting and diarrhoea (FDA paroxetine label, section 5.2). According to the European Medicines Agency (EMA) herbal monograph, the syndrome occurs very rarely with serotonin reuptake inhibitors (St John's wort herbal monograph, EMA, section 4.5).

Management

The Spanish St John's wort summary of product characteristics (SmPC) contraindicates the combination: St John's wort must not be used with antidepressants, especially selective serotonin reuptake inhibitors (SSRIs), and its interaction table names paroxetine (St John's wort SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, sections 4.3 and 4.5). The authorisation of this product has been suspended since 11 June 2026, and there is no other current Spanish St John's wort SmPC. The paroxetine SmPC is less strict: it advises caution and close monitoring of the patient when paroxetine is combined with serotonergic agents, St John's wort preparations among them (paroxetine SmPC, AEMPS, section 4.5). If serotonin syndrome occurs, stop paroxetine and start supportive symptomatic treatment (paroxetine SmPC, AEMPS, section 4.4); the label of the US Food and Drug Administration (FDA) also says to stop other serotonergic medicines immediately (FDA paroxetine label, sections 5.2 and 7). No document says how long to wait between stopping St John's wort and starting paroxetine. Increased enzyme activity returns to normal within 1 week of stopping St John's wort (St John's wort herbal monograph, European Medicines Agency, EMA, section 4.5).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Hypericum perforatum

Other interactions with Paroxetine